sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
25 Nov 2009
22.89USD
$22.89
25 Nov 2009
+0.00%
$22.89
--
957,976
$22.96
$22.72
$26.14
$15.75
0.49
877,420
News
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Kimmel, Roger |
Chairman of the Board |
-- |
| Holveck, David |
President, Chief Executive Officer, Director |
1,960,620 |
| Levin, Alan |
Chief Financial Officer, Executive Vice President |
-- |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$2,684.06 |
| Shares Outstanding (Mil.) |
117.26 |
| Float (Mil.) |
115.10 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
0.00 |
| |
| Financial Strength |
| Quick Ratio |
2.85 |
| Current Ratio |
1.93 |
| LT Debt/Equity |
23.67 |
| Total Debt/Equity |
23.67 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
13.86 |
| Price/Sales(TTM) |
1.89 |
| Price/Book(TTM) |
2.00 |
| Price/Cash Flow(TTM) |
10.17 |
| |
|
| Per Share Data |
| Earnings(TTM) |
$1.66 |
| Sales(TTM) |
$12.08 |
| Book Value(MRQ) |
$11.47 |
| Cash Flow(TTM) |
$2.25 |
| Cash(MRQ) |
$4.07 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
16.25 |
| Return on Assets(TTM) |
8.88 |
| Return on Investment(TTM) |
11.54 |
| |
|
| Margins |
| Gross Margin(TTM) % |
75.04 |
| Operating Margin(TTM) % |
24.26 |
| Profit Margin(TTM) % |
13.65 |
|
| |
|